Angiplast Profile
Key Indicators
- Authorised Capital ₹ 6.50 M
- Paid Up Capital ₹ 6.00 M
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 32.03 Cr
- Satisfied Charges ₹ 5.06 Cr
- Revenue Growth 4.29%
- Profit Growth -1.03%
- Ebitda 5.08%
- Net Worth 8.17%
- Total Assets 8.58%
About Angiplast
Angiplast Private Limited (APL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 January 1994 and has a history of 31 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 M and a paid-up capital of Rs 6.00 M.
The company currently has active open charges totaling ₹32.03 Cr. The company has closed loans amounting to ₹5.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashit Shah and Aditya Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33119GJ1994PTC021072
- Company No.
021072
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1994
- Date of AGM
27 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Angiplast Private Limited offer?
Angiplast Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, NICU Equipments, Infusion Syringes & Supplies, Medical Tubes, Oxygen Mask, Flowmeter & Humidifier Bottle, Urological & Obstetrics Instruments, Urinary Catheter, Oxygen Mask, Surgical & Medical Consumables, Surgical Disposables.
Who are the key members and board of directors at Angiplast?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashit Shah  | Director | 18-Jan-1994 | Current |
| Aditya Shah | Director | 01-Oct-2022 | Current |
Financial Performance of Angiplast.
Angiplast Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.29% increase. The company also saw a slight decrease in profitability, with a 1.03% decrease in profit. The company's net worth moved up by a moderate rise of 8.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angiplast?
In 2022, Angiplast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹320.25 M
₹50.63 M
Charges Breakdown by Lending Institutions
- The Kalupur Commercial Co-Operative Bank Limited : 31.48 Cr
- The Kalupur Commercial Co-Op. Bank Ltd. : 0.35 Cr
- The Kalupur Commercial Co Op Bank Ltd : 0.10 Cr
- The Kalupur Commercial Co. - Operative Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2024 | The Kalupur Commercial Co-Operative Bank Limited | ₹9.65 M | Open |
| 24 Mar 2023 | The Kalupur Commercial Co-Operative Bank Limited | ₹5.40 M | Open |
| 24 Mar 2023 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.66 Cr | Open |
| 16 Sep 2022 | The Kalupur Commercial Co-Operative Bank Limited | ₹1.50 Cr | Open |
| 19 Mar 2021 | The Kalupur Commercial Co-Operative Bank Limited | ₹2.56 M | Open |
How Many Employees Work at Angiplast?
Angiplast has a workforce of 35 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angiplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angiplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
